Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

ABEO Insider Trading

Abeona Therapeutics Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Abeona Therapeutics Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2023-09-29 23:30 2023-09-27 Silverstein Christine Berni Director SELL $3.91 6,330 $24,721 87,884 -6.7%
2023-09-29 23:30 2023-09-27 Alvino Mark Director SELL $3.91 6,316 $24,724 69,900 -8.3%
2023-09-22 23:05 2023-09-20 Amoroso Michael Director SELL $3.90 327 $1,275 114,465 -0.3%
2023-09-20 16:00 2023-09-19 Vazzano Joseph Walter Officer - Chief Financial Officer BUY $3.82 3,000 $11,458 238,179 +1.3%
2023-09-19 16:00 2023-09-18 O'Malley Brendan M. Officer - SVP, General Counsel BUY $3.80 3,000 $11,400 187,421 +1.6%
2023-06-21 23:05 2023-06-20 Amoroso Michael Director SELL $4.45 338 $1,504 114,792 -0.3%
2023-05-05 23:05 2023-04-25 Alvino Mark Director SELL $3.25 887 $2,883 17,527 -4.8%
2023-03-22 00:13 2023-03-20 Amoroso Michael Director SELL $2.33 268 $624 56,441 -0.5%
2023-03-04 03:06 2023-03-03 Amoroso Michael Director SELL $2.38 1,002 $2,385 56,709 -1.7%
2022-12-13 00:10 2022-12-09 O'Malley Brendan M. Officer - SVP, General Counsel BUY $3.13 5,869 $18,370 93,830 +6.7%
2022-11-21 17:00 2022-11-18 O'Malley Brendan M. Officer - SVP, General Counsel BUY $3.99 7,500 $29,925 87,961 +9.3%
2022-11-21 17:00 2022-11-18 Vazzano Joseph Walter Officer - Chief Financial Officer BUY $4.00 2,500 $10,000 95,250 +2.7%
2022-06-17 23:17 2022-06-15 Alvino Mark Director SELL $0.15 20,000 $3,098 27,181 -42.4%
2022-06-07 23:05 2022-06-06 Alvino Mark Director SELL $0.16 35,000 $5,464 47,181 -42.6%
2021-12-09 03:05 2021-12-06 O'Malley Brendan M. Officer - SVP, General Counsel SELL $0.57 8,880 $5,035 204,750 -4.2%
2021-11-06 02:00 2021-11-05 O'Malley Brendan M. Officer - SVP, General Counsel SELL $0.89 8,880 $7,894 213,630 -4.0%
2021-10-14 02:08 2021-10-11 O'Malley Brendan M. Officer - SVP, General Counsel SELL $0.90 25,734 $23,271 222,510 -10.4%
2021-10-09 03:31 2021-10-05 O'Malley Brendan M. Officer - SVP, General Counsel SELL $1.05 25,210 $26,483 248,244 -9.2%
2021-10-09 03:33 2021-10-07 Wider Todd Director SELL $0.97 25,000 $24,150 0 -100.0%
2021-10-09 03:29 2021-10-08 CARR EDWARD Officer - Chief Financial Officer SELL $1.05 29,122 $30,596 400,169 -6.8%
2021-10-04 23:06 2021-09-30 Amoroso Michael Director, Officer - Chief Executive Officer SELL $1.09 45,409 $49,382 604,637 -7.0%
2021-05-05 23:05 2021-05-03 SCO CAPITAL PARTNERS LLC Director, 10% owner SELL $2.01 80,000 $160,888 11,079,292 -0.7%
2021-04-06 01:31 2021-04-01 CARR EDWARD Officer - Chief Accounting Officer SELL $1.82 55,445 $100,710 191,291 -22.5%
2021-04-03 02:12 2021-03-31 Amoroso Michael Director, Officer - Chief Executive Officer SELL $1.87 45,409 $84,919 650,046 -6.5%
2021-03-19 23:05 2021-03-18 SCO CAPITAL PARTNERS LLC Director, 10% owner SELL $2.23 80,000 $178,624 11,159,292 -0.7%
2021-02-24 00:14 2021-02-19 Mann Paul Elliot Director OPT+S $2.38 45,566 $108,502 0 0.0%
2021-02-24 00:05 2021-02-19 Wider Todd Director SELL $2.39 251,625 $601,057 25,000 -91.0%
2021-02-20 00:05 2021-02-17 Mann Paul Elliot Director SELL $2.34 132,664 $310,168 0 -100.0%
2021-02-20 00:05 2021-02-17 Wider Todd Director OPT+S $2.34 321,345 $753,072 276,625 0.0%
2021-02-19 00:05 2021-02-16 SCO CAPITAL PARTNERS LLC Director, 10% owner SELL $2.97 120,000 $356,808 11,239,292 -1.1%
2021-02-11 03:42 2021-02-08 SCO CAPITAL PARTNERS LLC Director, 10% owner SELL $3.01 240,000 $722,832 11,359,292 -2.1%
2021-01-20 02:48 2021-01-14 SCO CAPITAL PARTNERS LLC Director, 10% owner SELL $2.06 320,000 $658,528 11,599,292 -2.7%
2021-01-06 03:07 2021-01-04 Mann Paul Elliot Director SELL $1.54 30,488 $46,891 132,664 -18.7%
2021-01-06 03:09 2021-01-04 Wider Todd Director SELL $1.54 33,876 $52,064 276,625 -10.9%
2020-12-22 02:16 2020-12-18 Mann Paul Elliot Director SELL $1.59 17,079 $27,099 772,907 -2.2%
2020-12-03 00:25 2020-12-02 Mann Paul Elliot Director SELL $1.49 30,488 $45,369 789,986 -3.7%
2020-12-03 00:26 2020-12-02 Wider Todd Director SELL $1.49 33,876 $50,546 920,256 -3.6%
2020-11-25 02:46 2020-11-23 Wider Todd Director SELL $1.33 17,969 $23,981 954,132 -1.8%
2020-11-07 00:54 2020-11-02 Mann Paul Elliot Director SELL $1.04 30,488 $31,589 820,474 -3.6%
2020-11-07 00:55 2020-11-02 Wider Todd Director SELL $1.04 33,876 $35,106 972,101 -3.4%
2020-09-17 23:05 2020-09-15 SCO CAPITAL PARTNERS LLC Director, 10% owner SELL $2.00 1,989 $3,981 11,919,292 0.0%
2020-09-15 03:35 2020-09-10 SCO CAPITAL PARTNERS LLC Director, 10% owner SELL $2.07 78,011 $161,725 11,921,281 -0.7%
2020-08-19 23:05 2020-08-17 SCO CAPITAL PARTNERS LLC 10% owner SELL $2.85 80,000 $228,312 11,999,292 -0.7%
2020-03-20 23:14 2020-03-19 CARR EDWARD Officer - Chief Accounting Officer SELL $1.81 6,446 $11,667 13,554 -32.2%
2020-01-01 01:17 2019-12-24 Buono Stefano Director BUY $2.50 200,000 $500,000 270,000 +285.7%
2019-04-19 00:57 2019-04-08 Van Duyne Richard B Director BUY $7.71 6,000 $46,260 6,000 +100.0%
2019-04-12 17:20 2019-04-10 Buono Stefano Director BUY $7.80 70,000 $546,252 70,000 +100.0%
2019-04-11 01:39 2019-04-08 Howell Stephen B. Director BUY $7.77 4,000 $31,080 79,494 +5.3%
2016-09-28 15:34 2016-09-20 Wider Todd Director BUY $5.48 5,000 $27,400 75,000 +7.1%
2015-08-03 22:11 2015-07-31 Wider Todd Director BUY $5.50 20,000 $110,000 70,000 +40.0%
SHOW ENTRIES

How to Interpret $ABEO Trades

Not every insider transaction in Abeona Therapeutics Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ABEO shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for ABEO

Insider activity data for Abeona Therapeutics Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ABEO, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.